Lonza Benelux
Hoge Mosten 16
4822Nh Breda
NL
Lonza Benelux
Foundation date
1897
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - Analytical services
- #R&D Services - Cell culture
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Drug delivery
- #R&D Services - Fill & finish
Lonza is one of the world’s largest companies for contract development and manufacturing, recognized for reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and over 35 years of experience in mammalian cell culture.
Lonza customers need to maintain high productivity, product quality and reproducibility when moving from the research phase into clinical and commercial manufacturing, rapidly bringing candidates to the clinic and products to market. A successful outcome will often require significant technical expertise and advanced development and manufacturing technologies.
In Lonza’s extensive contract development and manufacturing services portfolio, Lonza uses advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins. Their biologics offering spans from preclinical services, clinical drug product and drug substance and commercial supply in Mammalian, Microbial, ADCs / Bioconjugates, mRNA and Cell & Gene Therapies.
Lonza works in partnership with customers of all sizes, from start-ups to large biotechs and pharmaceutical companies, and can tailor our products and services to your specific needs, budget and timelines
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
New way of twisting fibers improves energy storage in wearable devices
Friday November 22nd 2024
Read more
-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
Thursday November 21st 2024
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
Jobs
More jobs-
24/11/24
Flemish Brabant
Postdoctoral researcher to develop antisense therapies for familial Alzheimer’s Disease
Permanent
VIB -
-
22/11/24
Flemish Brabant
ERC-funded postdoctoral position on engineering gut bacteria for live biotherapeutic applications
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator